s6y

Veraxa Biotech AG - Post de-SPAC

Ticker
VRXA, VRXAW
CIK
2079109
Industry
Pharmaceutical Preparations
Formerly
Veraxa Biotech Holding AG

Ownership 13

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 3 Initial statement of beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 3 Initial statement of beneficial ownership of securities
  7. 3 Initial statement of beneficial ownership of securities
  8. 3 Initial statement of beneficial ownership of securities
  9. 3 Initial statement of beneficial ownership of securities
  10. 3 Initial statement of beneficial ownership of securities

All 13 ownership filings

Prospectus 6

  1. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  2. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  3. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  4. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  5. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  6. 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Other 38

  1. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  2. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  3. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  4. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  5. SCHEDULE 13G/A
  6. EFFECT Notice of Effectiveness
  7. EFFECT Notice of Effectiveness
  8. F-1/A Registration statement for securities of certain foreign private issuers
  9. F-1/A Registration statement for securities of certain foreign private issuers
  10. F-1 Registration statement for securities of certain foreign private issuers

All 38 other filings